87 coding-"https:"-"Prof"-"FEMTO-ST" "https:" "https:" "https:" "https:" "https:" "https:" "Dr" "Dr" uni jobs at Cardiff University
Sort by
Refine Your Search
-
and Advanced therapeutics Laboratory (VITAL), in the research team of Dr Emily Bates. This funding is awarded by UKRI Proof of Concept Grant and will evaluate precision adenoviral therapies in mouse
-
through job-relevant training and development that you may require. 4. A mentoring scheme. For informal enquiries please contact Dr Kimberley Kendall KendallKM@cardiff.ac.uk We anticipate the interviews
-
Trust Career Development Award held by Dr Samuel Chawner entitled “Characterising the clinical heterogeneity and aetiology of Avoidant Restrictive Food Intake Disorder (ARFID)”. This is an exciting
-
hybrid working may be considered. For informal enquiries about the post, please contact Dr Emmanouil Perisoglou (Principal Investigator) at PerisoglouE@cardiff.ac.uk or Dr Juan Fernandez Goycoolea (Co
-
team player and be able to adapt to a broad range of duties and challenges. Informal enquiries about the post may be directed to Dr R Jenkins, Deputy School Manager (JenkinsR1@cardiff.ac.uk; 029 2087
-
part of the UKRI-funded Future Leader Fellowship project investigating epigenetic regulation of lung fibrosis led by Dr Renata Jurkowska at the School of Biosciences, Cardiff University. You will work
-
UK and SMF. For informal enquiries candidates should contact Dr James Pearson (Pearsonj1@cardiff.ac.uk). This post is part time (14 hours per week), available immediately for 8 months. Flexible working
-
to appropriate standards. Expertise in mammalian cell culture and/or iPSC culture is essential. Dr Connor-Robson’s group centers on the use of cutting-edge induced pluripotent stem cell (iPSC) models to study the
-
to work in the Viral ImmunoTherapies and Advanced therapeutics Laboratory (VITAL), in the research team of Dr Emily Bates. This funding is awarded by UKRI Proof of Concept Grant and will evaluate precision
-
the Viral ImmunoTherapies and Advanced therapeutics Laboratory (VITAL), in the research team of Dr Carly Bliss. This funding is awarded by Advancing Radiotherapy Cymru (ARC) and Cancer Research UK, and